FindTrial
Sign In

An Observational Study on Non-Invasive Fibrosis Assessment for Identifying MASLD/MASH Patients in Outpatient Settings

An Observational Study on Non-Invasive Fibrosis Assessment for Identifying MASLD/MASH Patients in Outpatient Settings

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1030250530
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-11-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with diabetes and dyslipidemia who have ALT > 30 IU/L

Interventions

None listed

Sponsors

Fukushima Yasushi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with dyslipidemia or diabetes Body Mass Index (BMI) >= 23 ALT > 30 IU/L Age >= 20 years Able to provide written informed consent voluntarily

Exclusion criteria

Exclusion criteria: History of liver disease (e.g., hepatitis B or C, autoimmune hepatitis) Excessive alcohol consumption (>= 30 g/day for men, >= 20 g/day for women) Pregnant or breastfeeding Cognitive impairment or other conditions that make it difficult to understand the study

Design outcomes

Primary

MeasureTime frame
Correlation between non-invasive fibrosis markers (FIB-4 index, M2BPGi) and liver stiffness measurement by FibroScan.—

Contacts

Public ContactAyako Sugiyama

Clinipro Co., Ltd.

sma@clinipro.co.jp+81-3-3243-0138

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026